DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rocaltrol (Calcitriol) - Published Studies

 
 



Rocaltrol Related Published Studies

Well-designed clinical trials related to Rocaltrol (Calcitriol)

Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? [2013]

Oral Calcitriol for Reduction of Proteinuria in Patients With IgA Nephropathy: A Randomized Controlled Trial. [2011.10.21]

Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. [2011.06.01]

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol. [2011.05]

Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients. [2011.03]

Response of plasma bone markers to a single intramuscular administration of calcitriol in dairy cows. [2011.02]

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. [2011.01]

Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. [2011]

Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. [2011]

Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. [2010.06]

Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients. [2010]

Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism. [2009.08]

Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. [2009.06]

Comparison of intermittent intravenous and oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients: a meta-analysis of randomized controlled trials. [2009.03]

The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass. [2009.03]

Calcium balance during calcitriol and paricalcitol administration in healthy humans. [2008.03]

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel. [2008.01.15]

Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. [2008.01]

Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. [2008]

Comparison of cutaneous tolerance and efficacy of calcitriol 3 mug g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. [2007.11]

Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. [2007.02.20]

Effects of a combined alendronate and calcitriol agent (Maxmarvil(R)) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. [2006.12]

Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure. [2006.11]

High dose calcitriol may reduce thrombosis in cancer patients. [2006.11]

Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial. [2006.10]

Calcitriol in the treatment of prostate cancer. [2006.07]

Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents. [2005.11]

Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients. [2005.09]

Randomized study on oral administration of calcitriol to prevent symptomatic hypocalcemia after total thyroidectomy. [2005.09]

ASCENT: the androgen-independent prostate cancer study of calcitriol enhancing taxotere. [2005.09]

Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. [2005.05]

Rationale for the development and current status of calcitriol in androgen-independent prostate cancer. [2005.02]

Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism. [2004.12]

Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy. [2004.12]

The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. [2004.11]

Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. [2004.10.27]

Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial. [2004.08]

The effects of calcitriol on falls and fractures and physical performance tests. [2004.05]

Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. [2004.04]

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. [2004.04]

Calcitriol in cancer treatment: from the lab to the clinic. [2004.03]

Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. [2004.02.19]

Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. [2004.02]

Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. [2003.11.27]

Comparative efficacy of oral and intravenous calcitriol treatment in haemodialysis patients: effects on serum biochemistry and cytokine levels. [2003.11]

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. [2003.09]

A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density. [2003.07]

Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol. [2003.06.27]

Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis. [2003.06]

Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis. [2003.05]

Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. [2003.05]

Growth in children with chronic renal failure on intermittent versus daily calcitriol. [2003.05]

Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate. [2003.04]

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. [2003.04]

Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. [2003.02]

Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy. [2003.01]

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers. [2002.11]

Clinical effect of intravenous calcitriol administration on secondary hyperparathyroidism. A double-blind study among 4 doses. [2002.04]

The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. [2002.02.27]

Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. [2002.02]

Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. [2001.11]

Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. [2001.09]

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. [2001.08]

The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. [2001.05]

Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis. [2001.04]

Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland. [2001.04]

Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. [2001.03]

Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study. [2001.03]

Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. [2000.12]

Calcitriol per os once, twice or three times a week: effect of different schedules of administration in hemodialysis patients. [2000.11]

A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients. [2000.10]

Effect of calcitriol on bone loss after cardiac or lung transplantation. [2000.09]

Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. [2000.08]

Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study. [2000.07]

Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure. [2000.07]

Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration. [2000.06]

Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale. [2000.03]

Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen. [2000.02.15]

A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial. [2000]

The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. [2000]

Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients. [2000]

Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women. [2000]

Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers. [2000]

Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy. [1999.12]

Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. [1999.08.27]

Calcitriol for bone disease in patients with cirrhosis of the liver. [1999.06]

Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. [1999.04.09]

A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia. [1999.04]

Calcitriol for bone loss in patients with primary biliary cirrhosis. [1999.04]

Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men. [1998.09]

Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. [1998.09]

Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women. [1998.06]

Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial. [1998.05]

Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure. [1998.04]

No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. [1997.07]

Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study. [1997.07]

A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 micrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris. [1997.05]

'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study. [1997]

Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis. [1997]

Effect of UVB phototherapy and oral calcitriol (1,25-dihydroxyvitamin D3) on vitamin D photosynthesis in patients with psoriasis. [1996.11]

Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. [1996.08.28]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017